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Thymus transplantation has great clinical potential
for treating immunological disorders, but the
shortage of transplant donors limits the progress of
this therapy. Human embryonic stem cells (hESCs)
are promising cell sources for generating thymic
epithelial cells. Here, we report a stepwise protocol
to direct the differentiation of hESCs into thymic
epithelial progenitor-like cells (TEPLCs) bymimicking
thymus organogenesis with sequential regulation of
Activin, retinoic acid, BMP, and WNT signals. The
hESC-derived TEPLCs expressed the key thymic
marker gene FOXN1 and could further develop in vivo
into thymic epithelium expressing the functional
thymic markers MHC II and AIRE upon transplanta-
tion.Moreover, the TEPLC-derived thymic epithelium
could supportmouse thymopoiesis inT-cell-deficient
mice and promote human T cell generation in NOD/
SCID mice engrafted with human hematopoietic
stem cells (hHSCs). These findings could facilitate
hESC-based replacement therapy and provide a
valuable in vitro platform for studying human thymus
organogenesis and regeneration.
INTRODUCTION
The thymus is the primary lymphoid organ of the immune system
responsible for T cell development. Dysfunction of the thymus
causes immune diseases ranging from immunodeficiency to
autoimmunity. Human thymus transplantation has been used
to treat immunodeficiency diseases such as DiGeorge syndrome
(Markert et al., 1999). Thymus transplantation also shows great
potential for promoting T cell regeneration in posttransplantation
immune deficiency and age-related thymic atrophy and inducing
immune tolerance to allografts (Chinn and Markert, 2011; Green
and Snoeck, 2011). Despite well-established clinical protocols230 Cell Stem Cell 13, 230–236, August 1, 2013 ª2013 Elsevier Inc.for thymus transplantation, the shortage of available donor cell
sources has limited the widespread application of this therapy
(Green and Snoeck, 2011).
hESCs are promising sources for cell replacement therapies
(Murry andKeller, 2008). Recently, the anterior foregut endoderm
(AFE), an early precursor for tissues such as the thymus and lung,
was derived fromhESCs (Green et al., 2011). However, it remains
unknown whether hESCs can be differentiated into thymic
epithelial progenitor cells (TEPCs) that can mature into thymic
epithelial cells (TECs) and support thymopoiesis in vivo (Bennett
et al., 2002; Gill et al., 2002; Rossi et al., 2006). In this study, we
demonstrated that human thymic epithelial progenitor-like cells
(TEPLCs) could be generated from hESCs in a stepwise manner,
mimicking in vivo thymus organogenesis.When transplanted into
nude mice, the TEPLCs further matured into thymic epithelium
and supported mouse T cell development. Moreover, the
TEPLC-derived thymic epithelium could also enhance human
T cell generation in NOD/SCID mice engrafted with hHSCs.RESULTS
EfficientDirectedDifferentiation of hESCs into theThird
PPE Cells
By mimicking in vivo thymus development (Blackburn and
Manley, 2004; Gordon and Manley, 2011; Rodewald, 2008), we
developed a three-step differentiation protocol to direct hESC
specification through stages resembling the definitive endoderm
(DE), the third pharyngeal pouch endoderm (PPE), and TEPCs
(Figure 1A).
As the thymus is a DE-derived organ (Zorn and Wells, 2009),
Activin A was used to differentiate hESCs into DE cells (D’Amour
et al., 2005). Activin A efficiently induced DE formation (Figure S1
available online). TheDE cells were further induced into third PPE
cells because thymic primordium originates from the third PPE
(Nowell et al., 2007). In vivo studies have demonstrated that
retinoid signaling is essential for initiating and patterning the third
PPE (Graham et al., 2005). Therefore, cells were exposed to
retinoic acid (RA) to induce third PPE specification in stage 2.
RA promoted the expression of the third PPE markers HOXA3,
Figure 1. Gene Expression Analysis of the Stepwise Differentiation of TEPLCs from hESCs
(A) Schematic of the three-step directed differentiation protocol. The growth factors/chemical compounds and duration of each stage are shown. Representative
genes from each stage are listed. hESCs, human embryonic stem cells; DE, definitive endoderm; PPE, pharyngeal pouch endoderm; TEPCs, thymic epithelial
progenitor cells; RA, all-trans Retinoic Acid; IWR1, inhibitor of WNT response 1; BMP4, bone morphogenetic protein 4.
(B) The expression of representative DE, AFE, and third PPE genes in cultures treated for 4 days with different signaling regulators at stage 2. Values represent
mean ± SEM. n = 3. R, RA; L, LE540; I, IWR1; W, WNT3a; D, DMSO. *p < 0.05.
(C) The expression of FOXN1 and K5 in cultures exposed to BMP4 (B) and/or WNT3a (W) for 5 days at stage 3. Values represent mean ± SEM. n = 3. **p < 0.01;
*p < 0.05.
(D) Kinetics analysis of expression of key genes involved in thymus development using Q-PCR. hFT was used as a control. D, day. Values represent mean ± SEM.
n = 3. The H1 cell line was used.
See also Figure S1 and Table S2.
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Thymic Epithelial Progenitors from Human ESCsTBX1, EYA1, and PBX1, while the RA inhibitor LE540 reduced
the expression of these genes compared with the RA treatment
(Figure 1B).
To further promote the effect of RA on the third PPE induction,
various signaling regulators combined with RA were tested. We
observed that IWR1, a canonical WNT signal inhibitor (Chen
et al., 2009), could upregulate the expression of HOXA3, EYA1,
TBX1, and PBX1 compared with RA treatment alone (Figure 1B).
IWR1 treatment also increased the expression of the AFE
markers SOX2 and FOXA2 and reduced the expression of
the DE marker SOX17 (Figure 1B). We also detected protein
expression of HOXA3, TBX1, SIX1, and PBX1 (Figures 2A, 2B,C2G, and 2H). In stage 2, about 60% of the obtained cells were
TBX1+EpCAM+ or HOXA3+EpCAM+ (Figures 2C–2F).
Further Directed Differentiation of the Third PPE into
TEPCs
To promote the differentiation of third PPE into TEPCs, we eval-
uated BMP and WNT signals using the expression of the TEPC
marker genes FOXN1, Keratin 5 (K5), and Keratin 8 (K8) (Nowell
et al., 2007). BMP4 andWNT signals have been implicated in the
regulation of Foxn1 expression in TECs (Balciunaite et al., 2002;
Tsai et al., 2003). We observed that the combination of BMP4
and WNT3a significantly augmented FOXN1 and K5 expressionell Stem Cell 13, 230–236, August 1, 2013 ª2013 Elsevier Inc. 231
Figure 2. Stepwise Differentiations of Third PPE and TEPCs from hESCs
(A–F) Analysis of the expression of the third PPEmarkers HOXA3 (A, C, andD) and TBX1 (B, E, and F) on D9. (A andB) Immunostaining for HOXA3 (A) and TBX1 (B).
Scale bars, 100 mm. (C and E) Representative flow cytometric analysis of the percentages of HOXA3+EpCAM+ (C) and TBX1+EpCAM+ cells (E). The isotype control
(left) and DMSO-treated control (middle) at stage 2 are shown. H1 cells were used for immunofluorescence and representative flow cytometric analysis. (D and F)
Statistical results of the percentages of HOXA3+EpCAM+ (D) and TBX1+EpCAM+ cells (F) quantified using flow cytometric analysis. Values represent mean ±
SEM. n = 4 for each cell line.
(G and H) Immunofluorescence of the expression of the third PPE markers SIX1 (G) and PBX1 (H) on D9. Scale bars, 100 mm. H1 cells were used.
(I–L) Analysis of the expression of the thymic marker FOXN1 (I) and TEPC marker K5+K8+ (J–L) on D14. (I and J) Immunostaining for FOXN1 (I) and K5 and K8 (J).
Scale bars, 100 mm. H1 cells were used. (K) Representative flow cytometric analysis of the percentages of K5+K8+ cells. The isotype control (left) and untreated
cells (middle) at stage 3 are shown. H9 cells were used. (L) Statistical analysis of the percentages of K5+K8+ cells quantified using flow cytometric analysis. Values
represent mean ± SEM. n = 3 for each cell line.
See also Figure S2.
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Thymic Epithelial Progenitors from Human ESCscompared with untreated controls (Figure 1C, p = 0.0009, p =
0.0197, respectively). Moreover, FOXN1 expression could be
detected by immunofluorescence (Figure 2I), implying the spec-
ification of thymic fate. The detection of approximately 30%
K5+K8+ cells further suggests a TEPC (K5+K8+) phenotype
(Klug et al., 1998) (Figures 2J–2L). Moreover, P63, a key regulator
of TEPC proliferation in development (Rodewald, 2008), was
detected in the K5+K8+ cells (Figure S2). In addition, PLET1, a
specific marker of mouse TEPCs (Depreter et al., 2008), could
also be detected (Figure S1A). These results indicate that
TEPLCs could be generated from hESCs. TEPLCs could be
derived from the hESC lines H1 and H9 (Figure 2L). As the effi-
ciency of thymic induction was similar between the two cell lines
(Figure 2L), we used H1-cell-derived TEPLCs in the later anal-
ysis, unless otherwise specified.232 Cell Stem Cell 13, 230–236, August 1, 2013 ª2013 Elsevier Inc.To evaluate whether our differentiation protocol mimics in vivo
thymus development, we analyzed the kinetics of key gene
expression in thymus development, which showed a sequential
transition fromDE through the third PPE to TEPCs (Figure 1D and
Figure S1A). These data indicate that the differentiation protocol
mimics in vivo thymus development.
hESC-Derived TEPLCs Mature into the Thymic
Epithelium In Vivo
To investigate whether TEPLCs resembled TEPCs, whichmature
into TECs in vivo, we transplanted TEPLCs into nude mice. The
TEPLCs were reaggregated with human embryonic fibroblasts
(HEFs) in vitro, a model based on reaggregate fetal thymic organ
culture (Anderson et al., 1993; Bennett et al., 2002), and then
transplanted in vivo (Figure 3A). HEFs, TEPLCs, and human fetal
Figure 3. Characterization of the Maturation of hESC-Derived TEPLCs In Vivo
(A) Schematic diagram of the protocol for hESC-derived TEPLC transplantation in the renal capsule of athymic nude mice.
(B–E) Confocal immunofluorescent analysis of the grafts recovered from TEPLC, TEPLC+HEF, and hFT recipient nude mice at 16 to 24 weeks post-
transplantation, followed by staining for MHC II and E-cadherin (B), AIRE and E-cadherin (C), K8 and K5 (D), and Thy1 and CD3 (E). Scale bars for (B)–(E): 50 mm;
insets, 5 mm.
See also Figure S3 and Table S1.
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Thymic Epithelial Progenitors from Human ESCsthymus (hFT) were transplanted as controls. At 16 to 24 weeks
posttransplantation, the grafts were recovered and analyzed.
We assessed the expression of human major histocompatibility
complex class II (MHC II) and AIRE by costaining with the epithe-
lialmarker E-cadherin.MHC II is a key functional TECmarker, and
AIRE is a key medullary TEC marker (Metzger and Anderson,
2011). MHC II+E-cadherin+ and AIRE+E-cadherin+ cells were
detected in all the grafts except HEF grafts (Figure 3B, C and Fig-
ures S3D andS3E). The threemarkers were not detected in HEFs
before transplantation (Figures S3A–S3C). The percentages of
MHC II+E-cadherin+ cells in the TEPLC, TEPLC+HEF, and hFT
grafts were 34.6%, 30.3%, and 82.3%, respectively (Table S1
available online). Notably, MHC II and AIRE were not detected
in the TEPLCs before transplantation (Figures S3B and S3C),
implying that the TEPLCs could further differentiate in vivo. We
also detected the expression of K5 and K8 in all grafts except
the HEF grafts (Figure 3D and Figure S3F). While K5+K8+ cells
were detected in both TEPLC and TEPLC+HEF grafts, a portion
of theK5+K8+ cells in the TEPLC+HEFgrafts showed significantly
reduced K8 expression and formed a cluster, implying that these
cells were medullary TECs (K5+K8) (Figure 3D and Figure S3G).
We further confirmed the expression of FOXN1, K5, MHC II,
and AIRE using Q-PCR (Figure S3H). The cortical TEC marker
PSMB11 (Tomaru et al., 2009) was also detected in the
TEPLC+HEF graft (Figure S3I). In addition, markers for other
AFE-derived tissues, including thyroid, parathyroid, and lung,
were not observed in the TEPLC+HEF graft, although thyroid
genemarkerswereweaklydetected in someTEPLCgrafts,which
might be due to the unpurification of the transplanted cells (Fig-
ure S3J). Taken together, these data suggest that hESC-derived
TEPLCs could further develop into the thymic epithelium in vivo.ChESC-Derived TEPLCs Enhance Mouse T Cell
Development In Vivo
To determine whether the hESC-derived TEPLCs support
thymopoiesis in vivo, we evaluated the capacity of TEPLCs
to restore thymopoiesis in nude mice, which exhibit severely
impaired T cell generation and function due to athymia. TEPLCs
reaggregated with HEFs were transplanted into BALB/c nude
mice. The detection of CD3+Thy1+ cells in the TEPLC and
TEPLC+HEF grafts suggested the presence of thymocytes
(Figure 3E). Both TEPLC and TEPLC+HEF grafts contained DP
cells (approximately 300 to 10,000 cells per graft), CD4+ single-
positive (SP) cells, and CD8+ SP cells, suggesting an undergoing
T cell development (Figure 4A). Rare double-positive (DP) cells
were detected in the HEF grafts (Figure 4A). Next, we analyzed
CD4+ and CD8+ cells in the peripheral blood lymphocytes (PBL)
at different time points posttransplantation. Similar to hFT-
recipient mice, the percentages of CD4+ cells in TEPLC+HEF
recipient mice were significantly higher than those in either
HEF recipientmiceor shamcontrols after 8weeksposttransplan-
tation (Figure 4B, Figure S4A, and Table S3). Similar results were
observed in TEPLC recipient mice at 12 weeks posttransplan-
tation (Figure 4B and Table S3). The efficient repopulation of
CD8+ cells in PBL was not observed (Figure S4B), which might
bedue to the failure ofmouseCD8+ cellmigration in a xenogeneic
thymusmicroenvironment (Zhao et al., 1997).We also performed
transplantation in CD1 nu/nu mice using both H1- and H9-cell-
derived TEPLCs, and similar results were observed (Figures
S4C and S4D).
The enhancement of mouse T cell generation in nude mice
could be caused by either de novo T cell generation or residual
T cell proliferation stimulated by xenogeneic human antigens.ell Stem Cell 13, 230–236, August 1, 2013 ª2013 Elsevier Inc. 233
Figure 4. hESC-Derived TEPLCs Support Mouse Thymopoiesis and Enhance Human T Cell Generation In Vivo
(A) Analysis of mouse CD4 andCD8 cells in grafts recovered fromBALB/c nudemice transplantedwith HEF, TEPLC, TEPLC+HEF, and hFT cells. Although 12.5%
of CD4+ T cells were observed in the HEF grafts, the number of CD4+ cells in the HEF grafts was extremely low.
(B) Kinetic analysis of CD4+ cells in the PBL of recipient mice (BALB/c nude). Sham controls were included. Values represent mean ± SEM. **p < 0.01; *p < 0.05.
(C–E) Analysis of the grafts for the presence of CD62L+CD44 cells (C), CD25+FoxP3+ cells (D), and CD3+TCRb+ cells (E).
(F) Analysis of the secretion of IL2 in splenic CD4+ cells after PMA and ionomycin treatment. Values represent mean ± SEM. **p < 0.01; *p < 0.05.
(G) Analysis of the proliferation index of splenic CD4+ cells at different time points after Con A stimulation. Values represent mean ± SEM. **p < 0.01; *p < 0.05.
(H) Analysis of human CD4+ (hCD4+) cells in hCD45+ PBL from sham controls and HEF and TEPLC+HEF transplanted NOD/SCID mice. Values represent
mean ± SEM.
(I) Analysis of grafts for the presence of human CD4+CD8+ DP cells from HEF, TEPLC+HEF, and hFT recipient NOD/SCID mice.
See also Figure S3 and Table S3.
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two T cell subtypes: CD3+CD62L+CD44 naive T cells and
CD4+CD25+FoxP3+ regulatory T cells (Tregs), the development
of which depend on TECs. CD3+CD62L+CD44 cells and
CD4+CD25+FoxP3+ cells were both detected in TEPLC and
TEPLC+HEF grafts, but not in HEF grafts (Figures 4C and 4D,
data not shown). These results suggest that de novo generation
of T cells might be supported by hESC-derived TEPLCs.
To evaluate the function of repopulated T cells, we analyzed
the expression of the T cell receptor (TCR), which is critical for
T cell activation. More than 70% of CD3+ cells in TEPLC or
TEPLC+HEF grafts were TCRb+ (Figure 4E). Occasionally
CD3TCRb+ cells were observed, which might originate from
the nonfunctional TCRa/b+ cells in the nude mice before trans-
plantation (Rocha, 1990). CD3+TCRb cells were also observed
on occasion, and TCRg/s+ cells were detected in these cells
(data not shown). Next, we evaluated the function of repopulated
T cells by detecting cytokine production after phorbol-12-myris-
tate-13-acetate (PMA) and ionomycin treatment. Compared with
the sham controls, a significant fraction of splenic CD4+ cells234 Cell Stem Cell 13, 230–236, August 1, 2013 ª2013 Elsevier Inc.from TEPLC and TEPLC+HEF recipient mice secreted IL2 (Fig-
ure 4F and Table S3). Moreover, to determine the proliferative
potential of repopulated T cells, the splenic CD4+ cells from
recipient mice were treated with the lymphocyte mitogen conca-
navalin A (Con A). The proliferation index (PI) of CD4+ cells from
TEPLC+HEF or TEPLC-recipient mice was significantly higher
than that of sham controls at 7 days poststimulation (Figure 4G
and Figure S4E).
To further evaluate whether the repopulated T cells could be
activated by antigen stimulation, splenic T cells from the recip-
ient mice were activated by anti-CD3/CD28 antibodies in vitro,
which partially mimicked stimulation by antigen-presenting cells
(Chen and Flies, 2013). Splenic CD3+ T cells from TEPLC+HEF-
recipient mice could be activated by anti-CD3/CD28 stimulation,
showing an enhanced PI compared with the sham controls
(Figures S4F and S4G). We next assessed the response of repo-
pulated T cells to alloantigen stimulation in a mixed leukocyte
reaction assay. A significant enhancement of splenocyte prolifer-
ation in response to alloantigenwas observed in the TEPLC+HEF
recipient mice compared with the sham controls (Figure S4H).
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support functional mouse T cell development in vivo.
hESC-Derived TEPLCs Have the Potential to Enhance
Human T Cell Generation In Vivo
Finally, we examined whether human T cell generation could
be supported by hESC-derived TEPLCs in a humanized mouse
model (Melkus et al., 2006). TEPLCs reaggregated with
HEFs were transplanted into immunodeficient NOD/SCID
mice engrafted with hHSCs. At 2 months posttransplantation,
enhanced human CD4+ cell generation was observed in the
PBL of TEPLC+HEF recipient mice compared with HEF recip-
ient mice and the sham controls (Figure 4H and Table S3).
Although the percentage of human CD4+ cells in the PBL of
TEPLC+HEF recipient mice was lower than that of hFT-recipient
mice (Figure 4H and Figure S4I), the generation of human
CD4+CD8+ DP, CD4+ SP, and CD8+ SP cells was observed in
the TEPLC+HEF grafts at a comparable level to that in the
hFT grafts (Figure 4I). These results imply that hESC-derived
TEPLCs have the potential of enhancing human T cell develop-
ment in vivo.
DISCUSSION
Here, we report a stepwise protocol for differentiating human
TEPLCs from hESCs. The TEPLCs could develop into thymic
epithelium in vivo. Furthermore, the TEPLC-derived thymic
epithelium could support mouse thymopoiesis and have the
potential of enhancing human T cell generation.
To mimic in vivo thymus organogenesis, several key signaling
pathways in thymus development were examined in our study.
The use of RA and BMP4+WNT3a in our protocol was consis-
tent with the reported involvement of RA, BMP, and WNT
signaling in thymus development (Nowell et al., 2007). Addition-
ally, RA and WNT inhibitors might also promote AFE generation
(Chen et al., 2007; Zorn and Wells, 2009) and are important for
the generation of AFE derivatives from ESCs (Longmire et al.,
2012; Mou et al., 2012; Wong et al., 2012). To generate hESC-
derived TEPLCs at a higher efficiency, it will be essential to
determine the mechanism underlying thymus development
and to identify key molecules that promote human TEPC induc-
tion from hESCs.
Importantly, the TEPLCs could further develop into the
thymic epithelium in vivo, which supports T cell development.
The overall efficiency of thymopoiesis in the TEPLC-recipient
and TEPLC+HEF-recipient mice was not comparable to that in
the hFT grafts. Several issues may account for this difference,
such as functional immaturity of TEPLCs, the unpurified TEPLCs
before transplantation, and an inefficient lympho-epithelial inter-
action betweenmouse lymphocytes and human TEPLCs (Ander-
son and Jenkinson, 2001). Further optimization of the protocol
for promoting the formation of a functional thymic microenvi-
ronment from hESC-derived TEPLCs in vivo might improve the
ability of TEPLCs to fully support T cell development.
In conclusion, the generation of human TEPLCs from hESCs
provides a potential in vitro model for exploring the mechanism
of human thymus development and thymus regeneration and
might facilitate the potential use of hESC-derived thymic epithe-
lial cells for future transplantation.CEXPERIMENTAL PROCEDURES
ESC Differentiation
H1 or H9 cells (WiCell) were differentiated using the X-VIVO 10 (Lonza) medium
as a basal medium. In stage 1, hESCs were treated with 100 ng/ml Activin A
(Peprotech) for 3 days. Then cells were replated and cultured with Activin A
for another 2 days. In stage 2, cells were treated with 1 mMall-trans RA (Sigma)
and 2.5 mM IWR1 (Tocris) for 4 days. In stage 3, 10 ng/ml BMP4 and 50 ng/ml
WNT3a (R&D) were used for differentiation. Detailed culture conditions are
outlined in the Supplemental Information.
Q-PCR
Q-PCR analysis was performed using the SYBR Green PCR Master Mix
(Applied Biosystems). Gene expression was normalized to GAPDH. Detailed
methods and primer sequences are available in the Supplemental Information.
Immunofluorescence
Cultures/sections were fixed with 4% paraformaldehyde and immunostained
with antibodies according tomethods detailed in the Supplemental Information.
Flow Cytometry
Single-cell suspensions were stained with antibodies and analyzed on FACS
Calibur, Aria III (BD) or Gallios (Beckman Coulter). FlowJo software (Ashland)
was used for data analysis. Detailed methods and antibodies are described
in the Supplemental Information.
Kidney Capsule Transplantation and Bone Marrow Transplantation
TEPLCs were reaggregated with HEFs to form solidified reaggregates, which
were retrieved and transplanted under the kidney capsule of nude mice or
NOD/SCID mice. One month before reaggregate transplanation, NOD/SCID
mice were sublethally irradiated and injected with 1–2 3 105 CD34+ human
fetal liver cells into the bone marrow cavity.
CFSE-Labeled Lymphocyte Stimulation Assay and IL2 Secretion
Assay
Splenocytes were stained with 5 mM CFSE (Invitrogen) for 15 min. For pro-
liferation assay, cells were then cultured in a 96-well plate in the presence of
1 mg/ml Con A (Sigma). For anti-CD3/CD28 stimulation assay, cells were
cultured in an anti-CD3 antibody precoated 96-well plate in the presence of
2 mg/ml anti-CD28 antibody (eBioscience). Cells were collected and stained
with the anti-CD4 or anti-CD3 antibody for flow cytometric analysis. PI values
were calculated using the ModFit software.
For IL2 secretion, splenocytes were treated with 37.5 ng/ml PMA and
1.5 mg/ml ionomycin (Sigma) and stained with anti-CD4 and anti-IL2 antibody.
Detailed procedures are available in the Supplemental Information.
Mixed Lymphocyte Reaction
Responder splenocytes (43 105) from transplanted BALB/c nudemice mixed
with 4 3 105 stimulator splenocytes (from C57, irradiated) were cultured at
37C in 5% CO2. On day 4, cells were pulsed and incubated with 1 mCi of
[3H]-labeled thymidine. Cells were harvested and assayed in the Wallac
Microbeta 1450 Luminometer Liquid Scintillation Counter.
Statistical Analysis
For statistical analysis, two-tailed unpaired t test was used. Results are
expressed as mean ± SEM. The p values of Figure 4 and Figure S4 are listed
in Table S3.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes Supplemental Experimental
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